A Study of Revumenib in Combination With Chemotherapy in Participants With R/R Acute Leukemia

Clinical trial NCT05326516 · COMPLETED

Trial details

NCT number: NCT05326516
Sponsor: Syndax Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Leukemias Acute Lymphoblastic Leukemia Acute Lymphocytic Leukemia Mixed Phenotype Acute Leukemia Acute Myeloid Leukemia Acute Undifferentiated Leukemia

Start date: 2022-03-09
Primary completion: 2024-07-29
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.